2024-09-092025-09-302025-09-30false15943996THE THERAPY SPACE CLINIC LTD2026-08-2082990falseiso4217:GBPxbrli:pure159439962024-09-08159439962025-09-30159439962024-09-092025-09-30159439962024-09-07159439962024-09-08159439962024-09-082024-09-0815943996bus:SmallEntities2024-09-092025-09-3015943996bus:AuditExempt-NoAccountantsReport2024-09-092025-09-3015943996bus:FullAccounts2024-09-092025-09-3015943996bus:PrivateLimitedCompanyLtd2024-09-092025-09-3015943996core:WithinOneYear2025-09-3015943996core:AfterOneYear2025-09-3015943996core:WithinOneYear2024-09-0815943996core:AfterOneYear2024-09-0815943996core:ShareCapital2025-09-3015943996core:SharePremium2025-09-3015943996core:RevaluationReserve2025-09-3015943996core:OtherReservesSubtotal2025-09-3015943996core:RetainedEarningsAccumulatedLosses2025-09-3015943996core:ShareCapital2024-09-0815943996core:SharePremium2024-09-0815943996core:RevaluationReserve2024-09-0815943996core:OtherReservesSubtotal2024-09-0815943996core:RetainedEarningsAccumulatedLosses2024-09-0815943996core:LandBuildings2025-09-3015943996core:PlantMachinery2025-09-3015943996core:Vehicles2025-09-3015943996core:FurnitureFittings2025-09-3015943996core:OfficeEquipment2025-09-3015943996core:NetGoodwill2025-09-3015943996core:IntangibleAssetsOtherThanGoodwill2025-09-3015943996core:ListedExchangeTraded2025-09-3015943996core:UnlistedNon-exchangeTraded2025-09-3015943996core:LandBuildings2024-09-0815943996core:PlantMachinery2024-09-0815943996core:Vehicles2024-09-0815943996core:FurnitureFittings2024-09-0815943996core:OfficeEquipment2024-09-0815943996core:NetGoodwill2024-09-0815943996core:IntangibleAssetsOtherThanGoodwill2024-09-0815943996core:ListedExchangeTraded2024-09-0815943996core:UnlistedNon-exchangeTraded2024-09-0815943996core:LandBuildings2024-09-092025-09-3015943996core:PlantMachinery2024-09-092025-09-3015943996core:Vehicles2024-09-092025-09-3015943996core:FurnitureFittings2024-09-092025-09-3015943996core:OfficeEquipment2024-09-092025-09-3015943996core:NetGoodwill2024-09-092025-09-3015943996core:IntangibleAssetsOtherThanGoodwill2024-09-092025-09-3015943996core:ListedExchangeTraded2024-09-092025-09-3015943996core:UnlistedNon-exchangeTraded2024-09-092025-09-3015943996core:MoreThanFiveYears2024-09-092025-09-3015943996core:Non-currentFinancialInstruments2025-09-3015943996core:Non-currentFinancialInstruments2024-09-0815943996dpl:CostSales2024-09-092025-09-3015943996dpl:DistributionCosts2024-09-092025-09-3015943996core:LandBuildings2024-09-092025-09-3015943996core:PlantMachinery2024-09-092025-09-3015943996core:Vehicles2024-09-092025-09-3015943996core:FurnitureFittings2024-09-092025-09-3015943996core:OfficeEquipment2024-09-092025-09-3015943996dpl:AdministrativeExpenses2024-09-092025-09-3015943996core:NetGoodwill2024-09-092025-09-3015943996core:IntangibleAssetsOtherThanGoodwill2024-09-092025-09-3015943996dpl:GroupUndertakings2024-09-092025-09-3015943996dpl:ParticipatingInterests2024-09-092025-09-3015943996dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-092025-09-3015943996core:ListedExchangeTraded2024-09-092025-09-3015943996dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-092025-09-3015943996core:UnlistedNon-exchangeTraded2024-09-092025-09-3015943996dpl:CostSales2024-09-082024-09-0815943996dpl:DistributionCosts2024-09-082024-09-0815943996core:LandBuildings2024-09-082024-09-0815943996core:PlantMachinery2024-09-082024-09-0815943996core:Vehicles2024-09-082024-09-0815943996core:FurnitureFittings2024-09-082024-09-0815943996core:OfficeEquipment2024-09-082024-09-0815943996dpl:AdministrativeExpenses2024-09-082024-09-0815943996core:NetGoodwill2024-09-082024-09-0815943996core:IntangibleAssetsOtherThanGoodwill2024-09-082024-09-0815943996dpl:GroupUndertakings2024-09-082024-09-0815943996dpl:ParticipatingInterests2024-09-082024-09-0815943996dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-082024-09-0815943996core:ListedExchangeTraded2024-09-082024-09-0815943996dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-082024-09-0815943996core:UnlistedNon-exchangeTraded2024-09-082024-09-0815943996core:NetGoodwill2025-09-3015943996core:IntangibleAssetsOtherThanGoodwill2025-09-3015943996core:LandBuildings2025-09-3015943996core:PlantMachinery2025-09-3015943996core:Vehicles2025-09-3015943996core:FurnitureFittings2025-09-3015943996core:OfficeEquipment2025-09-3015943996core:AfterOneYear2025-09-3015943996core:WithinOneYear2025-09-3015943996core:ListedExchangeTraded2025-09-3015943996core:UnlistedNon-exchangeTraded2025-09-3015943996core:ShareCapital2025-09-3015943996core:SharePremium2025-09-3015943996core:RevaluationReserve2025-09-3015943996core:OtherReservesSubtotal2025-09-3015943996core:RetainedEarningsAccumulatedLosses2025-09-3015943996core:NetGoodwill2024-09-0815943996core:IntangibleAssetsOtherThanGoodwill2024-09-0815943996core:LandBuildings2024-09-0815943996core:PlantMachinery2024-09-0815943996core:Vehicles2024-09-0815943996core:FurnitureFittings2024-09-0815943996core:OfficeEquipment2024-09-0815943996core:AfterOneYear2024-09-0815943996core:WithinOneYear2024-09-0815943996core:ListedExchangeTraded2024-09-0815943996core:UnlistedNon-exchangeTraded2024-09-0815943996core:ShareCapital2024-09-0815943996core:SharePremium2024-09-0815943996core:RevaluationReserve2024-09-0815943996core:OtherReservesSubtotal2024-09-0815943996core:RetainedEarningsAccumulatedLosses2024-09-0815943996core:NetGoodwill2024-09-0715943996core:IntangibleAssetsOtherThanGoodwill2024-09-0715943996core:LandBuildings2024-09-0715943996core:PlantMachinery2024-09-0715943996core:Vehicles2024-09-0715943996core:FurnitureFittings2024-09-0715943996core:OfficeEquipment2024-09-0715943996core:AfterOneYear2024-09-0715943996core:WithinOneYear2024-09-0715943996core:ListedExchangeTraded2024-09-0715943996core:UnlistedNon-exchangeTraded2024-09-0715943996core:ShareCapital2024-09-0715943996core:SharePremium2024-09-0715943996core:RevaluationReserve2024-09-0715943996core:OtherReservesSubtotal2024-09-0715943996core:RetainedEarningsAccumulatedLosses2024-09-0715943996core:AfterOneYear2024-09-092025-09-3015943996core:WithinOneYear2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:CostValuation2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943996core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3015943996core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3015943996core:Non-currentFinancialInstrumentscore:CostValuation2024-09-0815943996core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-0815943996core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-0815943996bus:Director12024-09-092025-09-30

THE THERAPY SPACE CLINIC LTD

Registered Number
15943996
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2025

THE THERAPY SPACE CLINIC LTD
Company Information
for the period from 9 September 2024 to 30 September 2025

Director

LOPEZ, Sharnelle

Registered Address

Forma House
40 Bowling Green Lane
London
EC1R 0NE

Registered Number

15943996 (England and Wales)
THE THERAPY SPACE CLINIC LTD
Balance Sheet as at
30 September 2025

Notes

2025

£

£

Fixed assets
Tangible assets3400
400
Current assets
Cash at bank and on hand8,327
8,327
Creditors amounts falling due within one year4(3,215)
Net current assets (liabilities)5,112
Total assets less current liabilities5,512
Net assets5,512
Capital and reserves
Called up share capital1
Profit and loss account5,511
Shareholders' funds5,512
The financial statements were approved and authorised for issue by the Director on 20 August 2026, and are signed on its behalf by:
LOPEZ, Sharnelle
Director
Registered Company No. 15943996
THE THERAPY SPACE CLINIC LTD
Notes to the Financial Statements
for the period ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Judgements and key sources of estimation uncertainty
In preparing these financial statements, certain accounting records (including bank statements and expense documentation) were not available to the directors/accountant at the time of preparation. Where this was the case, the affected balances have been prepared using management's best estimates based on the information available. These estimates will be reviewed and adjusted, if necessary, once the underlying records are obtained.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment20
2.Average number of employees

2025
Average number of employees during the year0
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions500500
At 30 September 25500500
Depreciation and impairment
Charge for year100100
At 30 September 25100100
Net book value
At 30 September 25400400
At 08 September 24--
4.Creditors: amounts due within one year

2025

£
Bank borrowings and overdrafts1,536
Taxation and social security1,199
Accrued liabilities and deferred income480
Total3,215